{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T05:52:27Z","timestamp":1793857947433,"version":"4.6.1"},"reference-count":155,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81770461"],"award-info":[{"award-number":["81770461"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.metabol.2022.155180","type":"journal-article","created":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T12:48:20Z","timestamp":1647521300000},"page":"155180","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Sterol carrier protein 2 in lipid metabolism and non-alcoholic fatty liver disease: Pathophysiology, molecular biology, and potential clinical implications"],"prefix":"10.1016","volume":"131","author":[{"given":"Can","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Ke","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.metabol.2022.155180_bb0005","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","article-title":"Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention","volume":"18","author":"Huang","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.metabol.2022.155180_bb0010","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/hep.25762","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association","volume":"55","author":"Chalasani","year":"2012","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.metabol.2022.155180_bb0015","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.metabol.2022.155180_bb0020","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1002\/hep.30251","article-title":"Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"69","author":"Younossi","year":"2019","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.metabol.2022.155180_bb0025","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nrgastro.2017.32","article-title":"Lipid droplets and liver disease: from basic biology to clinical implications","volume":"14","author":"Gluchowski","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"10","key":"10.1016\/j.metabol.2022.155180_bb0030","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.bbalip.2018.08.004","article-title":"Intake of stigmasterol and \u03b2-sitosterol alters lipid metabolism and alleviates NAFLD in mice fed a high-fat western-style diet","volume":"1863","author":"Feng","year":"2018","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"issue":"9","key":"10.1016\/j.metabol.2022.155180_bb0035","doi-asserted-by":"crossref","first-page":"11816","DOI":"10.1096\/fj.202000678R","article-title":"Liver CPT1A gene therapy reduces diet-induced hepatic steatosis in mice and highlights potential lipid biomarkers for human NAFLD","volume":"34","author":"Weber","year":"2020","journal-title":"FASEB J"},{"issue":"2","key":"10.1016\/j.metabol.2022.155180_bb0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0149728","article-title":"Sterol carrier Protein-2, a nonspecific lipid-transfer protein, in intracellular cholesterol trafficking in testicular leydig cells","volume":"11","author":"Li","year":"2016","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.metabol.2022.155180_bb0045","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.bbalip.2007.04.005","article-title":"Sterol carrier protein-2: new roles in regulating lipid rafts and signaling","volume":"1771","author":"Schroeder","year":"2007","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"10.1016\/j.metabol.2022.155180_bb0050","first-page":"1157","article-title":"Induction of peroxisomal lipid metabolism in mice fed a high-fat diet","volume":"4","author":"Kozawa","year":"2011","journal-title":"Mol Med Rep"},{"issue":"8","key":"10.1016\/j.metabol.2022.155180_bb0055","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1210\/endo.136.8.7628371","article-title":"Differential expression of hepatic sterol carrier proteins in the streptozotocin-treated diabetic rat","volume":"136","author":"McLean","year":"1995","journal-title":"Endocrinology"},{"issue":"8","key":"10.1016\/j.metabol.2022.155180_bb0060","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/BF02953020","article-title":"Reduced hepatic sterol carrier protein-2 expression in the streptozotocin treated diabetic rat","volume":"3","author":"McLean","year":"1995","journal-title":"Endocrine"},{"key":"10.1016\/j.metabol.2022.155180_bb0065","first-page":"593","article-title":"Ursodeoxycholic acid lowers bile lithogenicity by regulating SCP2 expression in rabbit cholesterol gallstone models","volume":"11","author":"Cui","year":"2012","journal-title":"EXCLI J"},{"issue":"6","key":"10.1016\/j.metabol.2022.155180_bb0070","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1172\/JCI117583","article-title":"Regulation of sterol carrier protein 2 (SCP2) gene expression in rat peritoneal macrophages during foam cell formation. A key role for free cholesterol content","volume":"94","author":"Hirai","year":"1994","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.metabol.2022.155180_bb0075","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0163-7827(01)00015-7","article-title":"Gene structure, intracellular localization, and functional roles of sterol carrier protein-2","volume":"40","author":"Gallegos","year":"2001","journal-title":"Prog Lipid Res"},{"issue":"2","key":"10.1016\/j.metabol.2022.155180_bb0080","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00018-002-8416-8","article-title":"Sterol carrier protein-2: structure reveals function","volume":"59","author":"Stolowich","year":"2002","journal-title":"Cell Mol Life Sci"},{"issue":"3","key":"10.1016\/j.metabol.2022.155180_bb0085","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1194\/jlr.M700460-JLR200","article-title":"Three-dimensional structure\/function analysis of SCP-2-like2 reveals differences among SCP-2 family members","volume":"49","author":"Dyer","year":"2008","journal-title":"J Lipid Res"},{"issue":"9","key":"10.1016\/j.metabol.2022.155180_bb0090","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/BF02533954","article-title":"Cholesterol interaction with recombinant human sterol carrier protein-2","volume":"30","author":"Colles","year":"1995","journal-title":"Lipids"},{"issue":"8","key":"10.1016\/j.metabol.2022.155180_bb0095","doi-asserted-by":"crossref","first-page":"4733","DOI":"10.1016\/S0021-9258(18)89132-3","article-title":"Sterol carrier protein 2 and fatty acid-binding protein. Separate and distinct physiological functions","volume":"260","author":"Scallen","year":"1985","journal-title":"J Biol Chem"},{"issue":"11","key":"10.1016\/j.metabol.2022.155180_bb0100","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1021\/bi026904+","article-title":"Sterol carrier protein-2 functions in phosphatidylinositol transfer and signaling","volume":"42","author":"Schroeder","year":"2003","journal-title":"Biochemistry"},{"issue":"40","key":"10.1016\/j.metabol.2022.155180_bb0105","doi-asserted-by":"crossref","first-page":"13231","DOI":"10.1021\/bi990870x","article-title":"The sterol carrier protein-2 amino terminus: a membrane interaction domain","volume":"38","author":"Huang","year":"1999","journal-title":"Biochemistry"},{"issue":"22","key":"10.1016\/j.metabol.2022.155180_bb0110","doi-asserted-by":"crossref","first-page":"5915","DOI":"10.1021\/bi800251e","article-title":"Structure and function of the sterol carrier protein-2 N-terminal presequence","volume":"47","author":"Martin","year":"2008","journal-title":"Biochemistry"},{"issue":"1","key":"10.1016\/j.metabol.2022.155180_bb0115","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0009-3084(99)00128-0","article-title":"A potential role for sterol carrier protein-2 in cholesterol transfer to mitochondria","volume":"105","author":"Gallegos","year":"2000","journal-title":"Chem Phys Lipids"},{"issue":"39","key":"10.1016\/j.metabol.2022.155180_bb0120","doi-asserted-by":"crossref","first-page":"12592","DOI":"10.1021\/bi0491200","article-title":"Sterol carrier protein-2-facilitated intermembrane transfer of cholesterol- and phospholipid-derived hydroperoxides","volume":"43","author":"Vila","year":"2004","journal-title":"Biochemistry"},{"issue":"1","key":"10.1016\/j.metabol.2022.155180_bb0125","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0009-3084(95)02436-M","article-title":"Sterol carrier protein-2 stimulates intermembrane sterol transfer by direct membrane interaction","volume":"76","author":"Woodford","year":"1995","journal-title":"Chem Phys Lipids"},{"issue":"24","key":"10.1016\/j.metabol.2022.155180_bb0130","doi-asserted-by":"crossref","first-page":"5641","DOI":"10.1111\/j.1742-4658.2006.05553.x","article-title":"Characterization of SCP-2 from Euphorbia lagascae reveals that a single Leu\/Met exchange enhances sterol transfer activity","volume":"273","author":"Viitanen","year":"2006","journal-title":"FEBS J"},{"issue":"1","key":"10.1016\/j.metabol.2022.155180_bb0135","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.bpj.2009.03.063","article-title":"Fatty acid transfer from yarrowia lipolytica sterol carrier protein 2 to phospholipid membranes","volume":"97","author":"Falomir Lockhart","year":"2009","journal-title":"Biophys J"},{"issue":"12","key":"10.1016\/j.metabol.2022.155180_bb0140","doi-asserted-by":"crossref","first-page":"5988","DOI":"10.1016\/S0021-9258(19)69117-9","article-title":"Accelerated transfer of neutral glycosphingolipids and ganglioside GM1 by a purified lipid transfer protein","volume":"256","author":"Bloj","year":"1981","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2022.155180_bb0145","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/978-1-4939-1441-8_30","article-title":"Binding and cytotoxic trafficking of cholesterol hydroperoxides by sterol carrier protein-2","volume":"1208","author":"Girotti","year":"2015","journal-title":"Methods Mol Biol"},{"issue":"Pt 2","key":"10.1016\/j.metabol.2022.155180_bb0150","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1042\/bj3440593","article-title":"Interaction of the N-terminus of sterol carrier protein 2 with membranes: role of membrane curvature","volume":"2","author":"Huang","year":"1999","journal-title":"Biochem J 344 Pt"},{"issue":"40","key":"10.1016\/j.metabol.2022.155180_bb0155","doi-asserted-by":"crossref","first-page":"12149","DOI":"10.1021\/bi0260536","article-title":"Role of the sterol carrier protein-2 N-terminal membrane binding domain in sterol transfer","volume":"41","author":"Huang","year":"2002","journal-title":"Biochemistry"},{"issue":"8","key":"10.1016\/j.metabol.2022.155180_bb0160","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.bbalip.2006.07.002","article-title":"The role of electrostatics in protein-membrane interactions","volume":"1761","author":"Mulgrew-Nesbitt","year":"2006","journal-title":"Biochim Biophys Acta"},{"issue":"8","key":"10.1016\/j.metabol.2022.155180_bb0165","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.bbapap.2009.04.006","article-title":"Biophysical characterisation and urea-induced unfolding of recombinant yarrowia lipolytica sterol carrier protein-2","volume":"1794","author":"Burgardt","year":"2009","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"10.1016\/j.metabol.2022.155180_bb0170","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1006\/jmbi.1999.3355","article-title":"NMR structure of the sterol carrier protein-2: implications for the biological role","volume":"295","author":"Garc\u00eda","year":"2000","journal-title":"J Mol Biol"},{"issue":"1","key":"10.1016\/j.metabol.2022.155180_bb0175","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/0005-2760(89)90209-9","article-title":"Transfer of cholesterol and oxysterol derivatives by the nonspecific lipid transfer protein (sterol carrier protein 2): a study on its mode of action","volume":"1004","author":"van Amerongen","year":"1989","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.metabol.2022.155180_bb0180","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/B978-0-12-024922-0.50007-2","article-title":"Sterol carrier and lipid transfer proteins","volume":"22","author":"Vahouny","year":"1987","journal-title":"Adv Lipid Res"},{"issue":"4","key":"10.1016\/j.metabol.2022.155180_bb0185","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1042\/bst0200818","article-title":"Participation of sterol carrier protein-2 in cholesterol metabolism","volume":"20","author":"Kesav","year":"1992","journal-title":"Biochem Soc Trans"},{"issue":"9","key":"10.1016\/j.metabol.2022.155180_bb0190","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/hepr.12634","article-title":"Liraglutide ameliorates non-alcoholic fatty liver disease by enhancing mitochondrial architecture and promoting autophagy through the SIRT1\/SIRT3-FOXO3a pathway","volume":"46","author":"Tong","year":"2016","journal-title":"Hepatol Res"},{"issue":"21","key":"10.1016\/j.metabol.2022.155180_bb0195","doi-asserted-by":"crossref","first-page":"34258","DOI":"10.18632\/oncotarget.15946","article-title":"Foxo3a-dependent bim transcription protects mice from a high fat diet via inhibition of activation of the NLRP3 inflammasome by facilitating autophagy flux in kupffer cells","volume":"8","author":"Liu","year":"2017","journal-title":"Oncotarget"},{"issue":"50","key":"10.1016\/j.metabol.2022.155180_bb0200","doi-asserted-by":"crossref","first-page":"13948","DOI":"10.1021\/acs.jafc.9b05910","article-title":"A new possible mechanism by which punicalagin protects against liver injury induced by type 2 diabetes mellitus: upregulation of autophagy via the Akt\/FoxO3a signaling pathway","volume":"67","author":"Zhang","year":"2019","journal-title":"J Agric Food Chem"},{"issue":"1","key":"10.1016\/j.metabol.2022.155180_bb0205","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1194\/jlr.M300111-JLR200","article-title":"Regulation of sterol carrier protein gene expression by the forkhead transcription factor FOXO3a","volume":"45","author":"Dansen","year":"2004","journal-title":"J Lipid Res"},{"issue":"2","key":"10.1016\/j.metabol.2022.155180_bb0210","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1385\/ENDO:14:2:253","article-title":"Characterization of a steroidogenic factor-1-binding site found in promoter of sterol carrier protein-2 gene","volume":"14","author":"Lopez","year":"2001","journal-title":"Endocrine"},{"issue":"2","key":"10.1016\/j.metabol.2022.155180_bb0215","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1365-2583.2009.00959.x","article-title":"Yellow fever mosquito sterol carrier protein-2 gene structure and transcriptional regulation","volume":"19","author":"Vyazunova","year":"2010","journal-title":"Insect Mol Biol"},{"issue":"47","key":"10.1016\/j.metabol.2022.155180_bb0220","doi-asserted-by":"crossref","first-page":"11280","DOI":"10.1021\/bi00111a013","article-title":"Regulated expression of sterol carrier protein 2 in the ovary: a key role for cyclic AMP","volume":"30","author":"Rennert","year":"1991","journal-title":"Biochemistry"},{"issue":"5","key":"10.1016\/j.metabol.2022.155180_bb0225","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1194\/jlr.M800647-JLR200","article-title":"Metabolomics reveals a novel vitamin E metabolite and attenuated vitamin E metabolism upon PXR activation","volume":"50","author":"Cho","year":"2009","journal-title":"J Lipid Res"},{"issue":"10","key":"10.1016\/j.metabol.2022.155180_bb0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0046948","article-title":"THAP and ATF-2 regulated sterol carrier protein-2 promoter activities in the larval midgut of the yellow fever mosquito, Aedes aegypti","volume":"7","author":"Peng","year":"2012","journal-title":"PLoS One"},{"issue":"16","key":"10.1016\/j.metabol.2022.155180_bb0235","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20164063","article-title":"MicroRNA-15a regulates the differentiation of intramuscular preadipocytes by targeting ACAA1, ACOX1 and SCP2 in chickens","volume":"20","author":"Li","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.metabol.2022.155180_bb0240","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1080\/21691401.2019.1652625","article-title":"Methylation dependent microRNA 1285-5p and sterol carrier proteins 2 in type 2 diabetes mellitus","volume":"47","author":"Bai","year":"2019","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"5","key":"10.1016\/j.metabol.2022.155180_bb0245","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0022-2275(20)39694-2","article-title":"Regulation of sterol carrier protein-2 gene expression in rat liver and small intestine","volume":"34","author":"Baum","year":"1993","journal-title":"J Lipid Res"},{"issue":"33","key":"10.1016\/j.metabol.2022.155180_bb0250","doi-asserted-by":"crossref","first-page":"25547","DOI":"10.1074\/jbc.M000431200","article-title":"Pro-sterol carrier protein-2: role of the N-terminal presequence in structure, function, and peroxisomal targeting","volume":"275","author":"Schroeder","year":"2000","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.metabol.2022.155180_bb0255","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S0022-2275(20)32140-4","article-title":"Expression and intracellular processing of the 58 kDa sterol carrier protein-2\/3-oxoacyl-CoA thiolase in transfected mouse L-cell fibroblasts","volume":"40","author":"Atshaves","year":"1999","journal-title":"J Lipid Res"},{"issue":"33","key":"10.1016\/j.metabol.2022.155180_bb0260","doi-asserted-by":"crossref","first-page":"21277","DOI":"10.1016\/S0021-9258(17)31960-9","article-title":"Sterol carrier protein X is peroxisomal 3-oxoacyl coenzyme a thiolase with intrinsic sterol carrier and lipid transfer activity","volume":"269","author":"Seedorf","year":"1994","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.metabol.2022.155180_bb0265","doi-asserted-by":"crossref","first-page":"C1259","DOI":"10.1152\/ajpcell.2000.279.4.C1259","article-title":"Sterol carrier protein-2 localization in endoplasmic reticulum and role in phospholipid formation","volume":"279","author":"Starodub","year":"2000","journal-title":"Am J Physiol Cell Physiol"},{"issue":"4","key":"10.1016\/j.metabol.2022.155180_bb0270","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1083\/jcb.108.4.1353","article-title":"Subcellular localization of sterol carrier protein-2 in rat hepatocytes: its primary localization to peroxisomes","volume":"108","author":"Keller","year":"1989","journal-title":"J Cell Biol"},{"issue":"12","key":"10.1016\/j.metabol.2022.155180_bb0275","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41574-019-0256-9","article-title":"The regulation of hepatic fatty acid synthesis and partitioning: the effect of nutritional state","volume":"15","author":"Hodson","year":"2019","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"10.1016\/j.metabol.2022.155180_bb0280","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1055\/s-0035-1562945","article-title":"Fatty acid and glucose sensors in hepatic lipid metabolism: implications in NAFLD","volume":"35","author":"Vacca","year":"2015","journal-title":"Semin Liver Dis"},{"issue":"37","key":"10.1016\/j.metabol.2022.155180_bb0285","doi-asserted-by":"crossref","first-page":"11919","DOI":"10.1021\/bi00037a033","article-title":"Probing the ligand binding sites of fatty acid and sterol carrier proteins: effects of ethanol","volume":"34","author":"Schroeder","year":"1995","journal-title":"Biochemistry"},{"issue":"50","key":"10.1016\/j.metabol.2022.155180_bb0290","doi-asserted-by":"crossref","first-page":"31878","DOI":"10.1074\/jbc.271.50.31878","article-title":"Sterol carrier protein-2, a new fatty acyl coenzyme A-binding protein","volume":"271","author":"Frolov","year":"1996","journal-title":"J Biol Chem"},{"issue":"9","key":"10.1016\/j.metabol.2022.155180_bb0295","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.bcp.2013.02.007","article-title":"Betulinic acid alleviates non-alcoholic fatty liver by inhibiting SREBP1 activity via the AMPK-mTOR-SREBP signaling pathway","volume":"85","author":"Quan","year":"2013","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"10.1016\/j.metabol.2022.155180_bb0300","first-page":"507","article-title":"SREBP-1c, regulated by the insulin and AMPK signaling pathways, plays a role in nonalcoholic fatty liver disease","volume":"21","author":"Kohjima","year":"2008","journal-title":"Int J Mol Med"},{"issue":"4","key":"10.1016\/j.metabol.2022.155180_bb0305","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.cbpb.2009.04.003","article-title":"The effect of feed restriction on expression of hepatic lipogenic genes in broiler chickens and the function of SREBP1","volume":"153","author":"Wang","year":"2009","journal-title":"Comp Biochem Physiol B Biochem Mol Biol"},{"issue":"3","key":"10.1016\/j.metabol.2022.155180_bb0310","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3109\/10253890.2010.543444","article-title":"Dexamethasone-induced hepatic lipogenesis is insulin dependent in chickens (Gallus gallus domesticus)","volume":"14","author":"Cai","year":"2011","journal-title":"Stress"},{"issue":"2","key":"10.1016\/j.metabol.2022.155180_bb0315","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.tem.2007.10.009","article-title":"SREBPs: the crossroads of physiological and pathological lipid homeostasis","volume":"19","author":"Raghow","year":"2008","journal-title":"Trends Endocrinol Metab"},{"issue":"20","key":"10.1016\/j.metabol.2022.155180_bb0320","doi-asserted-by":"crossref","first-page":"10693","DOI":"10.1073\/pnas.94.20.10693","article-title":"Two sterol regulatory element-like sequences mediate up-regulation of caveolin gene transcription in response to low density lipoprotein free cholesterol","volume":"94","author":"Bist","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"32","key":"10.1016\/j.metabol.2022.155180_bb0325","doi-asserted-by":"crossref","first-page":"29342","DOI":"10.1074\/jbc.M202411200","article-title":"Ethanol induces fatty acid synthesis pathways by activation of sterol regulatory element-binding protein (SREBP)","volume":"277","author":"You","year":"2002","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.metabol.2022.155180_bb0330","doi-asserted-by":"crossref","first-page":"G387","DOI":"10.1152\/ajpgi.00460.2014","article-title":"Impact of SCP-2\/SCP-x gene ablation and dietary cholesterol on hepatic lipid accumulation","volume":"309","author":"Klipsic","year":"2015","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"9","key":"10.1016\/j.metabol.2022.155180_bb0335","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1194\/jlr.M300141-JLR200","article-title":"Sterol carrier protein-2\/sterol carrier protein-x expression differentially alters fatty acid metabolism in L cell fibroblasts","volume":"44","author":"Atshaves","year":"2003","journal-title":"J Lipid Res"},{"issue":"1","key":"10.1016\/j.metabol.2022.155180_bb0340","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1038\/s41467-020-16991-2","article-title":"Silencing hepatic MCJ attenuates non-alcoholic fatty liver disease (NAFLD) by increasing mitochondrial fatty acid oxidation","volume":"11","author":"Barbier-Torres","year":"2020","journal-title":"Nat Commun"},{"issue":"9","key":"10.1016\/j.metabol.2022.155180_bb0345","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1080\/15548627.2020.1834711","article-title":"TXNIP\/VDUP1 attenuates steatohepatitis via autophagy and fatty acid oxidation","volume":"17","author":"Park","year":"2020","journal-title":"Autophagy"},{"issue":"5","key":"10.1016\/j.metabol.2022.155180_bb0350","doi-asserted-by":"crossref","first-page":"G852","DOI":"10.1152\/ajpgi.00521.2005","article-title":"Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation","volume":"290","author":"Reddy","year":"2006","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"24","key":"10.1016\/j.metabol.2022.155180_bb0355","doi-asserted-by":"crossref","first-page":"9223","DOI":"10.1074\/jbc.RA118.002290","article-title":"Sterol carrier protein-2 deficiency attenuates diet-induced dyslipidemia and atherosclerosis in mice","volume":"293","author":"He","year":"2018","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.metabol.2022.155180_bb0360","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0005-2760(97)00003-9","article-title":"Sterol carrier protein-2 mediated cholesterol esterification in transfected L-cell fibroblasts","volume":"1345","author":"Murphy","year":"1997","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"10.1016\/j.metabol.2022.155180_bb0365","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/hep.23719","article-title":"Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites","volume":"52","author":"Neuschwander-Tetri","year":"2010","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.metabol.2022.155180_bb0370","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1002\/hep.21655","article-title":"Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis","volume":"45","author":"Yamaguchi","year":"2007","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.metabol.2022.155180_bb0375","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.febslet.2010.01.046","article-title":"Intrahepatic cholesterol influences progression, inhibition and reversal of non-alcoholic steatohepatitis in hyperlipidemic mice","volume":"584","author":"Wouters","year":"2010","journal-title":"FEBS Lett"},{"issue":"2","key":"10.1016\/j.metabol.2022.155180_bb0380","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.tem.2015.11.008","article-title":"The role of cholesterol in the pathogenesis of NASH","volume":"27","author":"Ioannou","year":"2016","journal-title":"Trends Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.metabol.2022.155180_bb0385","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/hep.26604","article-title":"Free cholesterol accumulation in hepatic stellate cells: mechanism of liver fibrosis aggravation in nonalcoholic steatohepatitis in mice","volume":"59","author":"Tomita","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2022.155180_bb0390","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12950-019-0211-5","article-title":"Accumulation of free cholesterol and oxidized low-density lipoprotein is associated with portal inflammation and fibrosis in nonalcoholic fatty liver disease","volume":"16","author":"Ho","year":"2019","journal-title":"J Inflamm (Lond)"},{"key":"10.1016\/j.metabol.2022.155180_bb0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2021.101109","article-title":"Hepatic cholesterol transport and its role in non-alcoholic fatty liver disease and atherosclerosis","volume":"83","author":"Li","year":"2021","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.metabol.2022.155180_bb0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101092","article-title":"Dysregulated lipid metabolism links NAFLD to cardiovascular disease","volume":"42","author":"Deprince","year":"2020","journal-title":"Mol Metab"},{"issue":"7","key":"10.1016\/j.metabol.2022.155180_bb0405","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19072034","article-title":"New aspects of lipotoxicity in nonalcoholic steatohepatitis","volume":"19","author":"Mendez-Sanchez","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.metabol.2022.155180_bb0410","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.redox.2014.09.005","article-title":"Mitochondrial cholesterol accumulation in alcoholic liver disease: role of ASMase and endoplasmic reticulum stress","volume":"3","author":"Mar\u00ed","year":"2014","journal-title":"Redox Biol"},{"issue":"10","key":"10.1016\/j.metabol.2022.155180_bb0415","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.tem.2015.07.006","article-title":"Ceramides - lipotoxic inducers of metabolic disorders","volume":"26","author":"Chaurasia","year":"2015","journal-title":"Trends Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.metabol.2022.155180_bb0420","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.96151","article-title":"LRH-1 regulates hepatic lipid homeostasis and maintains arachidonoyl phospholipid pools critical for phospholipid diversity","volume":"3","author":"Miranda","year":"2018","journal-title":"JCI Insight"},{"issue":"11","key":"10.1016\/j.metabol.2022.155180_bb0425","first-page":"1","article-title":"Hepatic triglyceride accumulation via endoplasmic reticulum stress-induced SREBP-1 activation is regulated by ceramide synthases","volume":"51","author":"Kim","year":"2019","journal-title":"Exp Mol Med"},{"issue":"3","key":"10.1016\/j.metabol.2022.155180_bb0430","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.cmet.2007.12.007","article-title":"Paracrine activation of hepatic CB1 receptors by stellate cell-derived endocannabinoids mediates alcoholic fatty liver","volume":"7","author":"Jeong","year":"2008","journal-title":"Cell Metab"},{"key":"10.1016\/j.metabol.2022.155180_bb0435","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.abb.2015.06.009","article-title":"Loss of L-FABP, SCP-2\/SCP-x, or both induces hepatic lipid accumulation in female mice","volume":"580","author":"Martin","year":"2015","journal-title":"Arch Biochem Biophys"},{"issue":"5","key":"10.1016\/j.metabol.2022.155180_bb0440","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s11745-017-4249-y","article-title":"Effect of Fabp1\/Scp-2\/Scp-x ablation on whole body and hepatic phenotype of phytol-fed male mice","volume":"52","author":"Landrock","year":"2017","journal-title":"Lipids"},{"issue":"2","key":"10.1016\/j.metabol.2022.155180_bb0445","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1194\/jlr.M200306-JLR200","article-title":"Hepatic overexpression of sterol carrier protein-2 inhibits VLDL production and reciprocally enhances biliary lipid secretion","volume":"44","author":"Amigo","year":"2003","journal-title":"J Lipid Res"},{"issue":"6","key":"10.1016\/j.metabol.2022.155180_bb0450","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1053\/gast.2000.20198","article-title":"Sterol carrier protein 2 gene transfer changes lipid metabolism and enterohepatic sterol circulation in mice","volume":"119","author":"Zanlungo","year":"2000","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.metabol.2022.155180_bb0455","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.cmet.2012.04.004","article-title":"Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver disease","volume":"15","author":"Min","year":"2012","journal-title":"Cell Metab"},{"issue":"5","key":"10.1016\/j.metabol.2022.155180_bb0460","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1002\/hep.26088","article-title":"Cholesterol and nonalcoholic fatty liver disease: renewed focus on an old villain","volume":"56","author":"Kerr","year":"2012","journal-title":"Hepatology"},{"issue":"51","key":"10.1016\/j.metabol.2022.155180_bb0465","doi-asserted-by":"crossref","first-page":"48058","DOI":"10.1074\/jbc.M106732200","article-title":"Disruption of the sterol carrier protein 2 gene in mice impairs biliary lipid and hepatic cholesterol metabolism","volume":"276","author":"Fuchs","year":"2001","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.metabol.2022.155180_bb0470","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0163-7827(01)00010-8","article-title":"Sterol regulatory element-binding proteins (SREBPs): transcriptional regulators of lipid synthetic genes","volume":"40","author":"Shimano","year":"2001","journal-title":"Prog Lipid Res"},{"issue":"9","key":"10.1016\/j.metabol.2022.155180_bb0475","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1172\/JCI0215593","article-title":"SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver","volume":"109","author":"Horton","year":"2002","journal-title":"J Clin Invest"},{"issue":"14","key":"10.1016\/j.metabol.2022.155180_bb0480","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1161\/01.CIR.0000143163.76212.0B","article-title":"ACAT2 is localized to hepatocytes and is the major cholesterol-esterifying enzyme in human liver","volume":"110","author":"Parini","year":"2004","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.metabol.2022.155180_bb0485","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1194\/jlr.M200191-JLR200","article-title":"ACBP and cholesterol differentially alter fatty acyl CoA utilization by microsomal ACAT","volume":"44","author":"Chao","year":"2003","journal-title":"J Lipid Res"},{"issue":"1\u20132","key":"10.1016\/j.metabol.2022.155180_bb0490","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1023\/A:1007001614939","article-title":"Sterol carrier protein-2 suppresses microsomal acyl-CoA hydrolysis","volume":"205","author":"Jolly","year":"2000","journal-title":"Mol Cell Biochem"},{"issue":"1","key":"10.1016\/j.metabol.2022.155180_bb0495","doi-asserted-by":"crossref","first-page":"G244","DOI":"10.1152\/ajpgi.00446.2009","article-title":"Effect of sterol carrier protein-2 gene ablation on HDL-mediated cholesterol efflux from cultured primary mouse hepatocytes","volume":"299","author":"Storey","year":"2010","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"1","key":"10.1016\/j.metabol.2022.155180_bb0500","doi-asserted-by":"crossref","first-page":"G36","DOI":"10.1152\/ajpgi.00510.2004","article-title":"Liver fatty acid binding protein gene ablation potentiates hepatic cholesterol accumulation in cholesterol-fed female mice","volume":"290","author":"Martin","year":"2006","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"9","key":"10.1016\/j.metabol.2022.155180_bb0505","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1016\/S0022-2275(20)37551-9","article-title":"Fibroblast membrane sterol kinetic domains: modulation by sterol carrier protein-2 and liver fatty acid binding protein","volume":"37","author":"Frolov","year":"1996","journal-title":"J Lipid Res"},{"issue":"7","key":"10.1016\/j.metabol.2022.155180_bb0510","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1194\/jlr.M900020-JLR200","article-title":"Overexpression of sterol carrier protein-2 differentially alters hepatic cholesterol accumulation in cholesterol-fed mice","volume":"50","author":"Atshaves","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1016\/j.metabol.2022.155180_bb0515","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.abb.2015.10.018","article-title":"Relative contributions of L-FABP, SCP-2\/SCP-x, or both to hepatic biliary phenotype of female mice","volume":"588","author":"Martin","year":"2015","journal-title":"Arch Biochem Biophys"},{"issue":"11","key":"10.1016\/j.metabol.2022.155180_bb0520","doi-asserted-by":"crossref","first-page":"G1130","DOI":"10.1152\/ajpgi.00209.2014","article-title":"Ablating L-FABP in SCP-2\/SCP-x null mice impairs bile acid metabolism and biliary HDL-cholesterol secretion","volume":"307","author":"Martin","year":"2014","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"2","key":"10.1016\/j.metabol.2022.155180_bb0525","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/hep.23721","article-title":"Transgenic expression of cholesterol 7alpha-hydroxylase in the liver prevents high-fat diet-induced obesity and insulin resistance in mice","volume":"52","author":"Li","year":"2010","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.metabol.2022.155180_bb0530","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1194\/jlr.M069807","article-title":"Cholesterol 7alpha-hydroxylase protects the liver from inflammation and fibrosis by maintaining cholesterol homeostasis","volume":"57","author":"Liu","year":"2016","journal-title":"J Lipid Res"},{"issue":"1","key":"10.1016\/j.metabol.2022.155180_bb0535","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1042\/bj2300019","article-title":"Regulation of bile-acid synthesis. Role of sterol carrier protein 2 in the biosynthesis of 7 alpha-hydroxycholesterol","volume":"230","author":"Seltman","year":"1985","journal-title":"Biochem J"},{"issue":"7","key":"10.1016\/j.metabol.2022.155180_bb0540","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/0020-711X(87)90228-X","article-title":"Cholesterol metabolism and sterol carrier protein-2 (non-specific lipid transfer protein)","volume":"19","author":"Geelen","year":"1987","journal-title":"Int J Biochem"},{"issue":"8","key":"10.1016\/j.metabol.2022.155180_bb0545","doi-asserted-by":"crossref","first-page":"G824","DOI":"10.1152\/ajpgi.00195.2011","article-title":"Intracellular cholesterol-binding proteins enhance HDL-mediated cholesterol uptake in cultured primary mouse hepatocytes","volume":"302","author":"Storey","year":"2012","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"2","key":"10.1016\/j.metabol.2022.155180_bb0550","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/0005-2760(96)00044-6","article-title":"Sterol carrier protein-2 expression in mouse L-cell fibroblasts alters cholesterol uptake","volume":"1302","author":"Moncecchi","year":"1996","journal-title":"Biochim Biophys Acta"},{"issue":"10","key":"10.1016\/j.metabol.2022.155180_bb0555","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1194\/jlr.M700102-JLR200","article-title":"SCP-2\/SCP-x gene ablation alters lipid raft domains in primary cultured mouse hepatocytes","volume":"48","author":"Atshaves","year":"2007","journal-title":"J Lipid Res"},{"issue":"10","key":"10.1016\/j.metabol.2022.155180_bb0560","doi-asserted-by":"crossref","first-page":"6490","DOI":"10.1074\/jbc.272.10.6490","article-title":"Sterol carrier protein-2 overexpression enhances sterol cycling and inhibits cholesterol ester synthesis and high density lipoprotein cholesterol secretion","volume":"272","author":"Baum","year":"1997","journal-title":"J Biol Chem"},{"issue":"47","key":"10.1016\/j.metabol.2022.155180_bb0565","doi-asserted-by":"crossref","first-page":"36852","DOI":"10.1074\/jbc.M003434200","article-title":"Sterol carrier protein-2 alters high density lipoprotein-mediated cholesterol efflux","volume":"275","author":"Atshaves","year":"2000","journal-title":"J Biol Chem"},{"issue":"14","key":"10.1016\/j.metabol.2022.155180_bb0570","doi-asserted-by":"crossref","first-page":"14140","DOI":"10.1074\/jbc.M311061200","article-title":"Expression of caveolin-1 enhances cholesterol efflux in hepatic cells","volume":"279","author":"Fu","year":"2004","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.metabol.2022.155180_bb0575","doi-asserted-by":"crossref","first-page":"C1204","DOI":"10.1152\/ajpcell.2001.280.5.C1204","article-title":"Influence of caveolin-1 on cellular cholesterol efflux mediated by high-density lipoproteins","volume":"280","author":"Frank","year":"2001","journal-title":"Am J Physiol Cell Physiol"},{"issue":"23","key":"10.1016\/j.metabol.2022.155180_bb0580","doi-asserted-by":"crossref","first-page":"7288","DOI":"10.1021\/bi035914n","article-title":"Sterol carrier protein-2 directly interacts with caveolin-1 in vitro and in vivo","volume":"43","author":"Zhou","year":"2004","journal-title":"Biochemistry"},{"issue":"28","key":"10.1016\/j.metabol.2022.155180_bb0585","doi-asserted-by":"crossref","first-page":"8301","DOI":"10.1021\/bi7002636","article-title":"A new N-terminal recognition domain in caveolin-1 interacts with sterol carrier protein-2 (SCP-2)","volume":"46","author":"Parr","year":"2007","journal-title":"Biochemistry"},{"issue":"9","key":"10.1016\/j.metabol.2022.155180_bb0590","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1194\/jlr.M069682","article-title":"Intracellular cholesterol transport proteins enhance hydrolysis of HDL-CEs and facilitate elimination of cholesterol into bile","volume":"57","author":"Wang","year":"2016","journal-title":"J Lipid Res"},{"issue":"4","key":"10.1016\/j.metabol.2022.155180_bb0595","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1194\/jlr.M053454","article-title":"The combination of ezetimibe and ursodiol promotes fecal sterol excretion and reveals a G5G8-independent pathway for cholesterol elimination","volume":"56","author":"Wang","year":"2015","journal-title":"J Lipid Res"},{"issue":"25","key":"10.1016\/j.metabol.2022.155180_bb0600","doi-asserted-by":"crossref","first-page":"16237","DOI":"10.1073\/pnas.252582399","article-title":"Disruption of Abcg5 and Abcg8 in mice reveals their crucial role in biliary cholesterol secretion","volume":"99","author":"Yu","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.metabol.2022.155180_bb0605","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.cmet.2016.10.001","article-title":"Transintestinal cholesterol transport is active in mice and humans and controls ezetimibe-induced fecal neutral sterol excretion","volume":"24","author":"Jakulj","year":"2016","journal-title":"Cell Metab"},{"issue":"2","key":"10.1016\/j.metabol.2022.155180_bb0610","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.tem.2017.11.006","article-title":"Cholesterol transport revisited: a new turbo mechanism to drive cholesterol excretion","volume":"29","author":"de Boer","year":"2018","journal-title":"Trends Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.metabol.2022.155180_bb0615","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1194\/jlr.M600174-JLR200","article-title":"Localization and role of NPC1L1 in cholesterol absorption in human intestine","volume":"47","author":"San\u00e9","year":"2006","journal-title":"J Lipid Res"},{"issue":"5","key":"10.1016\/j.metabol.2022.155180_bb0620","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1053\/j.gastro.2016.12.037","article-title":"Intestinal farnesoid X receptor controls transintestinal cholesterol excretion in mice","volume":"152","author":"de Boer","year":"2017","journal-title":"Gastroenterology"},{"issue":"1\u20132","key":"10.1016\/j.metabol.2022.155180_bb0625","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s11010-020-03826-3","article-title":"NPC1L1 and ABCG5\/8 induction explain synergistic fecal cholesterol excretion in ob\/ob mice co-treated with PPAR-\u03b1 and LXR agonists","volume":"473","author":"Srivastava","year":"2020","journal-title":"Mol Cell Biochem"},{"issue":"29","key":"10.1016\/j.metabol.2022.155180_bb0630","doi-asserted-by":"crossref","first-page":"19211","DOI":"10.1074\/jbc.M109.014860","article-title":"Activation of the liver X receptor stimulates trans-intestinal excretion of plasma cholesterol","volume":"284","author":"van der Veen","year":"2009","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.metabol.2022.155180_bb0635","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1172\/JCI119170","article-title":"High density lipoproteins, but not other lipoproteins, provide a vehicle for sterol transport to bile","volume":"99","author":"Robins","year":"1997","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.metabol.2022.155180_bb0640","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/00041433-200406000-00007","article-title":"Hepatic cholesterol transport from plasma into bile: implications for gallstone disease","volume":"15","author":"Zanlungo","year":"2004","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.metabol.2022.155180_bb0645","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/978-90-481-8622-8_10","article-title":"Caveolin, sterol carrier protein-2, membrane cholesterol-rich microdomains and intracellular cholesterol trafficking","volume":"51","author":"Schroeder","year":"2010","journal-title":"Subcell Biochem"},{"issue":"Pt 3","key":"10.1016\/j.metabol.2022.155180_bb0650","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1042\/bj3170681","article-title":"Modulation of intrahepatic cholesterol trafficking: evidence by in vivo antisense treatment for the involvement of sterol carrier protein-2 in newly synthesized cholesterol transport into rat bile","volume":"317","author":"Puglielli","year":"1996","journal-title":"Biochem J"},{"issue":"9","key":"10.1016\/j.metabol.2022.155180_bb0655","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/sj.cdd.4401284","article-title":"The endocannabinoid system, anandamide and the regulation of mammalian cell apoptosis","volume":"10","author":"Maccarrone","year":"2003","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.metabol.2022.155180_bb0660","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/502542","article-title":"Endocannabinoid receptors gene expression in morbidly obese women with nonalcoholic fatty liver disease","volume":"2014","author":"Auguet","year":"2014","journal-title":"Biomed Res Int"},{"issue":"11","key":"10.1016\/j.metabol.2022.155180_bb0665","doi-asserted-by":"crossref","DOI":"10.3390\/cells8111311","article-title":"Roles of the hepatic endocannabinoid and apelin Systems in the Pathogenesis of liver fibrosis","volume":"8","author":"Melgar-Lesmes","year":"2019","journal-title":"Cells"},{"issue":"7","key":"10.1016\/j.metabol.2022.155180_bb0670","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1111\/j.1476-5381.2011.01397.x","article-title":"The endocannabinoid system as a key mediator during liver diseases: new insights and therapeutic openings","volume":"163","author":"Mallat","year":"2011","journal-title":"Br J Pharmacol"},{"issue":"6","key":"10.1016\/j.metabol.2022.155180_bb0675","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1053\/j.gastro.2010.06.064","article-title":"Splanchnic balance of free fatty acids, endocannabinoids, and lipids in subjects with nonalcoholic fatty liver disease","volume":"139","author":"Westerbacka","year":"2010","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.metabol.2022.155180_bb0680","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s12035-014-8651-7","article-title":"Sterol carrier protein-2: binding protein for endocannabinoids","volume":"50","author":"Liedhegner","year":"2014","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.metabol.2022.155180_bb0685","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.abb.2018.05.013","article-title":"Scp-2\/Scp-x ablation in Fabp1 null mice differentially impacts hepatic endocannabinoid level depending on dietary fat","volume":"650","author":"Martin","year":"2018","journal-title":"Arch Biochem Biophys"},{"issue":"50","key":"10.1016\/j.metabol.2022.155180_bb0690","doi-asserted-by":"crossref","first-page":"35455","DOI":"10.1074\/jbc.274.50.35455","article-title":"Aberrant oxidation of the cholesterol side chain in bile acid synthesis of sterol carrier protein-2\/sterol carrier protein-x knockout mice","volume":"274","author":"Kannenberg","year":"1999","journal-title":"J Biol Chem"},{"issue":"9841","key":"10.1016\/j.metabol.2022.155180_bb0695","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0140-6736(12)60367-5","article-title":"The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials","volume":"380","author":"Mihaylova","year":"2012","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.metabol.2022.155180_bb0700","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/eurheartj\/ehaa1011","article-title":"Low-density lipoprotein cholesterol reduction and statin intensity in myocardial infarction patients and major adverse outcomes: a swedish nationwide cohort study","volume":"42","author":"Schubert","year":"2021","journal-title":"Eur Heart J"},{"issue":"9756","key":"10.1016\/j.metabol.2022.155180_bb0705","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1016\/S0140-6736(10)61272-X","article-title":"Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the greek atorvastatin and coronary heart disease evaluation (GREACE) study: a post-hoc analysis","volume":"376","author":"Athyros","year":"2010","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.metabol.2022.155180_bb0710","doi-asserted-by":"crossref","first-page":"3846","DOI":"10.1016\/j.ijcard.2013.06.024","article-title":"Effect of intensive lipid lowering with atorvastatin on cardiovascular outcomes in coronary heart disease patients with mild-to-moderate baseline elevations in alanine aminotransferase levels","volume":"168","author":"Tikkanen","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.metabol.2022.155180_bb0715","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.metabol.2017.02.014","article-title":"The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease\/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement","volume":"71","author":"Athyros","year":"2017","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.metabol.2022.155180_bb0720","doi-asserted-by":"crossref","first-page":"116","DOI":"10.14309\/ajg.0000000000000845","article-title":"Effects of statin use on the development and progression of nonalcoholic fatty liver disease: a Nationwide nested case-control study","volume":"116","author":"Lee","year":"2021","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.metabol.2022.155180_bb0725","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.jhep.2015.05.006","article-title":"Statin use and non-alcoholic steatohepatitis in at risk individuals","volume":"63","author":"Dongiovanni","year":"2015","journal-title":"J Hepatol"},{"issue":"44","key":"10.1016\/j.metabol.2022.155180_bb0730","doi-asserted-by":"crossref","first-page":"45512","DOI":"10.1074\/jbc.M407461200","article-title":"Statin induction of liver fatty acid-binding protein (L-FABP) gene expression is peroxisome proliferator-activated receptor-alpha-dependent","volume":"279","author":"Landrier","year":"2004","journal-title":"J Biol Chem"},{"issue":"11","key":"10.1016\/j.metabol.2022.155180_bb0735","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1136\/gutjnl-2018-318146","article-title":"miRNAs and NAFLD: from pathophysiology to therapy","volume":"68","author":"Gjorgjieva","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.metabol.2022.155180_bb0740","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.addr.2018.01.009","article-title":"MicroRNAs in the pathogenesis and treatment of progressive liver injury in NAFLD and liver fibrosis","volume":"129","author":"Su","year":"2018","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"10.1016\/j.metabol.2022.155180_bb0745","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.diabres.2012.11.025","article-title":"Upregulation of miR-15b in NAFLD models and in the serum of patients with fatty liver disease","volume":"99","author":"Zhang","year":"2013","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.metabol.2022.155180_bb0750","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3389\/fphar.2017.00003","article-title":"New microRNA biomarkers for drug-induced steatosis and their potential to predict the contribution of drugs to non-alcoholic fatty liver disease","volume":"8","author":"L\u00f3pez-Riera","year":"2017","journal-title":"Front Pharmacol"},{"issue":"10","key":"10.1016\/j.metabol.2022.155180_bb0755","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/BF03000200","article-title":"Reduced hepatic LDL-receptor, 3-hydroxy-3-methylglutaryl coenzyme a reductase and sterol carrier protein-2 expression is associated with pregnancy loss in the diabetic rat","volume":"3","author":"McLean","year":"1995","journal-title":"Endocrine"},{"key":"10.1016\/j.metabol.2022.155180_bb0760","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-230X-11-10","article-title":"Overexpression of sterol carrier protein 2 in patients with hereditary cholesterol gallstones","volume":"11","author":"Cui","year":"2011","journal-title":"BMC Gastroenterol"},{"issue":"Pt 1","key":"10.1016\/j.metabol.2022.155180_bb0765","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1042\/bj3360033","article-title":"Sterol carrier protein 2 participates in hypersecretion of biliary cholesterol during gallstone formation in genetically gallstone-susceptible mice","volume":"336","author":"Fuchs","year":"1998","journal-title":"Biochem J"},{"issue":"6","key":"10.1016\/j.metabol.2022.155180_bb0770","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1053\/j.gastro.2018.09.010","article-title":"Expression of STING is increased in liver tissues from patients with NAFLD and promotes macrophage-mediated hepatic inflammation and fibrosis in mice","volume":"155","author":"Luo","year":"2018","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.metabol.2022.155180_bb0775","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41575-018-0009-6","article-title":"Triggering and resolution of inflammation in NASH","volume":"15","author":"Schuster","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049522000580?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049522000580?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:31:02Z","timestamp":1758429062000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049522000580"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":155,"alternative-id":["S0026049522000580"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2022.155180","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sterol carrier protein 2 in lipid metabolism and non-alcoholic fatty liver disease: Pathophysiology, molecular biology, and potential clinical implications","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2022.155180","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"155180"}}